Crossmark

Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1038/s41598-024-84890-3

Published Online: 2025-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Su, Jialin

Li, Yuning

Tan, Shuhua

Cheng, Tianli

Luo, Yongzhong

Zhang, Lemeng
Funding

Funding for this research was provided by:

Natural Science Foundation of Hunan Province National Health Commission (B202303027655)

Natural Science Foundation of Changsha Science and Technology Bureau (Kq2208150)

Wu Jieping Foundation of China (320.6750.2022-22-59)

Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2017B030314120)
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 24 October 2023

Accepted: 27 December 2024

First Online: 2 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below